Navigation Links
Anti-estrogen drug therapy reduces risk of invasive breast cancer in older women
Date:6/10/2008

an, however, develop into or raise the risk for a more serious, invasive cancer. Invasive cancers are more aggressive and have started to break through normal breast tissue barriers and invade surrounding areas.

"This research gives older women facing certain medical decisions another option," explained principal investigator Elizabeth Barrett-Connor, M.D., distinguished professor and Chief, Division of Epidemiology, Department of Family and Preventive Medicine, and a member of the Cancer Prevention and Control Program, UC San Diego School of Medicine. "For example, if a woman at risk for osteoporosis is considering taking medication, and has no history of blood clots or stroke, raloxifene might be a more appealing option due to its protective role in invasive breast cancer."

The RUTH trial, the world's largest study of women and heart disease, was a randomized, blinded, placebo-controlled trial conducted at 177 sites, in 26 countries, on five continents. Between June 1998 and August 2000, 10,101 postmenopausal women with coronary heart disease or several heart disease risk factors were randomly assigned to raloxifene or to placebo and followed for a median of 5.6 years. The 5,044 women who took raloxifene had a 55 percent reduction in risk of developing invasive ER-positive breast cancer as compared to the 5,057 women who took placebo.

The initial results of the RUTH trial were published in 2006. The reduction in breast cancer risk was consistent with findings from other trials that involved women who did not have heart disease. However, women who took raloxifene in the RUTH trial had an increased incidence of blood clots and fatal strokes compared to those who took placebo. Thus, the researchers concluded that women considering use of raloxifene need to weigh the risks and benefits.

Study author Deborah Grady, M.D., M.P.H., of the University of California, San Francisco, and colleagues examined the RUTH trial data in mor
'/>"/>

Contact: Kim Edwards
kedwards@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Vision restoration therapy shown to improve brain activity in brain injured patients
2. HIV therapy in pregnancy-data support WHO recommendations
3. Family-based treatment more effective than supportive psychotherapy in treating bulimia
4. Trial to Test Gene Therapy for Angina in Women
5. One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High
6. Aromatherapy Gift Line Sheds Humorous Light on Modern Therapy
7. Chemotherapy may be culprit for fatigue in breast cancer survivors
8. Atlanta Falcons Physical Therapy Centers Set to Launch This Fall
9. New Drug No Substitute for Standard Blood-Clot Therapy
10. Stem Cell Therapy Disappoints Against Rare Kidney Ailment
11. Nucletron Announces Management Buy-Out to More Effectively Meet the Demands of Its Customers and the Radiation Therapy Community
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... (PRWEB) October 31, 2014 Fundraising support for ... greater gains than losses. At noon on Monday, November 10 ... Hospital (SSMH), greater than 20 Susquehanna Health (SH) employees ... to raise awareness and funds for the new Cancer Center ... participants’ heads for this act of love and support to ...
(Date:10/31/2014)... for Healthy Neighborhoods (PRCHN) at Case Western Reserve ... in nearly $13.32 million in federal grants awarded ... The Centers for Disease Control and Prevention (CDC) ... five years. The funds will support the center,s ... environmental, and policy interventions that prevent and reduce ...
(Date:10/31/2014)... Monica Williams-Murphy MD , advanced care planning ... chaos that can occur for people who have not ... Americans who come into the emergency department facing the ... the moment and so are their families." She adds, ... catalyst for a family to get the critical conversations ...
(Date:10/31/2014)... 31, 2014 Activz Whole-Food Nutrition ... Silver line offering natural silver healing support† in ... a century, silver has been used to support natural ... products is the most advanced version available. This latest ... chemical structure that supports the existing healing mechanisms in ...
(Date:10/31/2014)... increases the risk of certain types of breast cancer ... studies show. One study of more than 3,200 ... risk for estrogen receptor-negative and progesterone receptor-positive breast tumors ... long time for white women, but now we are ... John, a senior research scientist at the Cancer Prevention ...
Breaking Medicine News(10 mins):Health News:Susquehanna Health Soldiers + Sailors Memorial Hospital Razing Heads to Fight Cancer 2Health News:Case Western Reserve, Cuyahoga County, YMCA of greater Cleveland: Public health grants 2Health News:Case Western Reserve, Cuyahoga County, YMCA of greater Cleveland: Public health grants 3Health News:This Thanksgiving or Christmas Family Gathering, Use The New App ListStuffFast to Start "The Conversation" With a Parent That Has No Plan For End-of-Life 2Health News:This Thanksgiving or Christmas Family Gathering, Use The New App ListStuffFast to Start "The Conversation" With a Parent That Has No Plan For End-of-Life 3Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 2Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 3Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 4Health News:Study Confirms Obesity-Breast Cancer Link for Blacks, Hispanics 2
... exercised during pregnancy needed less pain meds, study found ... during pregnancy reduces the amount of pain-killing medication requested ... that included 71 expectant mothers. , Half the ... week of aquarobics during their pregnancy, while the other ...
... the Dallas office of WHR Architects. Ms. Moran, nationally recognized ... Education, Science and Technology practice and broaden the talent base ... , "Anita,s experience and skills complement ... college and university clients," said Mark W. Vaughan AIA, ACHA, ...
... SPRINGFIELD, Mass., Nov. 21 Massachusetts Mutual Life,Insurance ... two,Co-Chief Operating Officers. , ... Officer, Executive Vice President,and Chief Investment Officer, will ... H. Reese, who remains Chairman and Chief Executive,Officer. ...
... NXTM ), a leading manufacturer of innovative ... 2008 Technology Fast 500, a,ranking of the 500 fastest ... America. Rankings are based on percentage of,fiscal year revenue ... more than 20,000 percent during this period. , ...
... by HIV/AIDS in New Jersey and Africa - , ... than 800 local Roche employees are participating in the ... support children infected and affected by HIV/AIDS in New Jersey and ... through the township of Nutley, collect donations for their efforts, and ...
... to take, has fewer side effects than chemotherapy, ... The cancer-fighting pill Iressa works as well as chemotherapy ... , Although neither therapy prolongs survival beyond eight months, ... be a better choice for patients who did not ...
Cached Medicine News:Health News:Aquarobics May Help Ease Labor 2Health News:Anita Moran AIA Joins WHR Dallas 2Health News:MassMutual Announces Promotions for Two Co-Chief Operating Officers 2Health News:MassMutual Announces Promotions for Two Co-Chief Operating Officers 3Health News:MassMutual Announces Promotions for Two Co-Chief Operating Officers 4Health News:MassMutual Announces Promotions for Two Co-Chief Operating Officers 5Health News:NxStage(R) Ranked 14th Fastest Growing Company in North America on Deloitte's 2008 Technology Fast 500 2Health News:NxStage(R) Ranked 14th Fastest Growing Company in North America on Deloitte's 2008 Technology Fast 500 3Health News:Roche Holds Sixth Annual Children's Walk in Nutley 2Health News:Roche Holds Sixth Annual Children's Walk in Nutley 3Health News:Roche Holds Sixth Annual Children's Walk in Nutley 4Health News:Iressa as Good as Chemotherapy for Lung Cancer 2Health News:Iressa as Good as Chemotherapy for Lung Cancer 3
(Date:10/31/2014)... Mich. , Oct. 31, 2014  Lycera ... modulators to treat autoimmune disease and cancer, today ... novel synthetic RORgamma agonist product candidates will be ... for Immunotherapy of Cancer (SITC) being held November ... Convention Center, National Harbor, MD.  The poster, entitled ...
(Date:10/31/2014)... -- British Journal of Urology International ... "male orgasmic dysfunction" with their doctor prior to any ... while preserving sexual function     ... paper in the British Journal of Urology International which ... with their doctors the likely impact of treatment options ...
(Date:10/31/2014)... DUBLIN , October 30, 2014 ... ) has announced the addition of the  "Process ...  conference to their offering.      (Logo: ... , Science and Risk Based Approach to Process ... Quality Risk Management FDA Process Validation ...
Breaking Medicine Technology:Lycera Announces Presentation of Data on Anti-Tumor Activity of Novel Synthetic RORgamma Agonists at Society for Immunotherapy of Cancer Meeting 2Sexual Dysfunction No Longer Inevitable When Treating Enlarged Prostate 2Process Validation in the US and EU (Workshop, London) 2Process Validation in the US and EU (Workshop, London) 3Process Validation in the US and EU (Workshop, London) 4
... 29, 2010 Reportlinker.com announces that a new ... 2010-2015 In-depth Research Report on ... http://www.reportlinker.com/p0356862/2010-2015-In-depth-Research-Report-on-China-Sodium-Fluoride-Industry.html Report SummaryBased on ... Bureau, General Administration of Custom, Ministry of Commerce ...
... Reportlinker.com announces that a new market research report ... The Outlook for Pharmaceuticals to 2012 ... Pharmaceuticals to 2012 is a new collection of management ... individual and highly-detailed analysis of each market, looking at ...
Cached Medicine Technology:Reportlinker Adds 2010-2015 In-depth Research Report on China Sodium Fluoride Industry 2Reportlinker Adds E7: The Outlook for Pharmaceuticals to 2012 2Reportlinker Adds E7: The Outlook for Pharmaceuticals to 2012 3Reportlinker Adds E7: The Outlook for Pharmaceuticals to 2012 4Reportlinker Adds E7: The Outlook for Pharmaceuticals to 2012 5
... many surgeons turn it down confidently knowing ... the going gets tough. More important are the ... and the technologically advanced fan we build into ... ups and overheating. The result is dependable, extreme ...
Mounted on a sturdy, molded headband,the Classic has a fully adjustable crown,strap and cushioning that adds to,your comfort....
Mounted on a fully adjustable molded,headband with crown strap and comfort,cushions, the sturdy Trueview Classic is,lightweight, comfortable and durable....
Mounted on a sturdy, molded headband,the Classic has a fully adjustable,crown strap and cushioning that adds,to your comfort....
Medicine Products: